Výsledky vyhledávání - "Jennifer Agahigian"

Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease

Autor: Kenneth N Sall, Michael H Goldstein, Todd A. Durham, Damien F. Goldberg, Jay Rubin, Marc Abrams, Jennifer Agahigian, Eric Furfine, Joseph R. Martel, John D. Sheppard, Michael S Korenfeld, Joseph Tauber

Publikováno v: Eye & Contact Lens: Science & Clinical Practice. 43:287-296

Isunakinra, formerly known as EBI-005, is a novel interleukin (IL)-1 receptor inhibitor developed for topical treatment of patients with dry eye disease (DED). This phase 1b/2a multicenter, double-masked, randomized, vehicle controlled environmental

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e347c1a5df0409e1e57fabae2ce3ec7
https://doi.org/10.1097/icl.0000000000000276

Zobrazit plný text záznamu

A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis

Autor: Eric Furfine, Karen L Tubridy, Kathryn Golden, Fiona Soong, Gregory Zarbis-Papastoitsis, Marianne Magill, Michael H Goldstein, Jennifer Agahigian, Anne Marie Salapatek, Joseph Kovalchin, Gary Sternberg, Abbie Celniker

Publikováno v: Eye & Contact Lens: Science & Clinical Practice. 41:145-155

OBJECTIVES Many allergic conjunctivitis (AC) patients are inadequately treated with conventional therapies or require steroids. EBI-005 was developed to address the late phase allergic response. This study's objectives were to evaluate two adapted cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff9f3a1e86020e7b8d3cfb4cbebd2d0
https://doi.org/10.1097/icl.0000000000000152

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání